Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model (Q36841356)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 2008
edit
Language Label Description Also known as
English
Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
scientific article published on September 2008

    Statements

    Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model (English)
    Carolyn Waugh Kinkade
    Anna Puzio-Kuter
    Jun Yan
    Thomas H Foster
    Hui Gao
    Yvonne Sun
    Xuesong Ouyang
    William L Gerald
    Cory Abate-Shen
    1 September 2008
    118
    3051-3064

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit